ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2021
What Cut-Point in Gait Speed Best Discriminates Community-Dwelling Older Adults With Mobility Complaints From Those Without? A Pooled Analysis From the Sarcopenia Definitions and Outcomes Consortium.
Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.
- Measurement properties of the usual and fast gait speed tests in community-dwelling older adults: a COSMIN-based systematic review.Age and ageing · 2024Pooled it
- Walking with a Passive Hip Exoskeleton and Wearables: Gait Characteristics and Metabolic Power in Senior Adults.Sensors (Basel, Switzerland) · 2025Trial
- Real-world walking and activity patterns in community-dwelling older adults: a cross-sectional analysis of baseline data from the SMART-AGE trial.European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2026Article
- Identification of signal-based gait features and blood analytes associated with stroke status and walking speed in mild acute ischemic stroke.BMC neurology · 2026Article
- Identification and Evaluation of the Additional Effect of Cognitive Training in Balance Physiotherapy.Journal of frailty, sarcopenia and falls · 2026Review
- Physical Indicators and Cutoff Values Associated with Improvement in Sarcopenia in Older Adults Undergoing Rehabilitation.Journal of frailty, sarcopenia and falls · 2026Article
- Long-term air pollution exposure and gait speed decline among older Adults: A longitudinal analysis.Environmental research · 2026Article
- Recent Sarcopenia Definitions-Variability in Prevalence and Disability Associations in Peritoneal Dialysis Patients.Journal of cachexia, sarcopenia and muscle · 2025Article
- Methodological Review of Classification Trees for Risk Stratification: An Application Example in the Obesity Paradox.Nutrients · 2025Review
- Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS).Aging clinical and experimental research · 2025Review
- Preliminary Characterization of Age and Chronic Low Back Pain Effects on Multimodal Pain Sensitivity: A Comparison Study in Older Adults with and Without Chronic Low Back Pain.The journal of pain · 2024Article
- Associations Between Walking Speed and Gut Microbiome Composition in Older Men From the MrOS Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024Article
- Optimal objective measurement of physical function and its predictive capacity for mortality among community-dwelling older women.Geriatrics & gerontology international · 2023Article
- Prevalence and Trends of Slow Gait Speed in the United States.Geriatrics (Basel, Switzerland) · 2023Article
- Prospective sarcopenia outcomes associated with physical performance in individuals aged 55 years and over in Malaysia.Frontiers in public health · 2023Article
- Cut-points of the 6-min walk test, the six spot step test, and the timed-25-foot walk test discriminating impaired from non-impaired walking capacity in persons with Multiple sclerosis.Multiple sclerosis journal - experimental, translational and clinicalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 18 institutions in 4 countries.
Funding
Abstract
backgroundCut-points to define slow walking speed have largely been derived from expert opinion.
methodsStudy participants (13 589 men and 5043 women aged ≥65years) had walking speed (m/s) measured over 4-6 m (mean ± SD: 1.20 ± 0.27 m/s in men and 0.94 ± 0.24 m/s in women.) Mobility limitation was defined as any self-reported difficulty with walking approximately 1/4 mile (prevalence: 12.6% men, 26.4% women). Sex-stratified classification and regression tree (CART) models with 10-fold cross-validation identified walking speed cut-points that optimally discriminated those who reported mobility limitation from those who did not.
resultsAmong 5043 women, CART analysis identified 2 cut-points, classifying 4144 (82.2%) with walking speed ≥0.75 m/s, which we labeled as "fast"; 478 (9.5%) as "intermediate" (walking speed ≥0.62 m/s but <0.75 m/s); and 421 (8.3%) as "slow" (walking speed <0.62 m/s). Among 13 589 men, CART analysis identified 3 cut-points, classifying 10 001 (73.6%) with walking speed ≥1.00 m/s ("very fast"); 2901 (21.3%) as "fast" (walking speed ≥0.74 m/s but <1.00 m/s); 497 (3.7%) as "intermediate" (walking speed ≥0.57 m/s but <0.74 m/s); and 190 (1.4%) as "slow" (walking speed <0.57 m/s). Prevalence of self-reported mobility limitation was lowest in the "fast" or "very fast" (11% for men and 19% for women) and highest in the "slow" (60.5% in men and 71.0% in women). Rounding the 2 slower cut-points to 0.60 m/s and 0.75 m/s reclassified very few participants.
conclusionsCut-points in walking speed of approximately 0.60 m/s and 0.75 m/s discriminate those with self-reported mobility limitation from those without.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.